96 related articles for article (PubMed ID: 12818732)
1. Antiatherosclerotic effects of beta-blockers.
Wikstrand J; Berglund G; Hedblad B; Hulthe J
Am J Cardiol; 2003 Jun; 91(12A):25H-29H. PubMed ID: 12818732
[TBL] [Abstract][Full Text] [Related]
2. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study.
Wiklund O; Hulthe J; Wikstrand J; Schmidt C; Olofsson SO; Bondjers G
Stroke; 2002 Feb; 33(2):572-7. PubMed ID: 11823672
[TBL] [Abstract][Full Text] [Related]
3. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).
Hedblad B; Wikstrand J; Janzon L; Wedel H; Berglund G
Circulation; 2001 Apr; 103(13):1721-6. PubMed ID: 11282901
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).
Ostling G; Gonçalves I; Wikstrand J; Berglund G; Nilsson J; Hedblad B
Atherosclerosis; 2011 Apr; 215(2):440-5. PubMed ID: 21315352
[TBL] [Abstract][Full Text] [Related]
5. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
[TBL] [Abstract][Full Text] [Related]
6. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
7. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
[TBL] [Abstract][Full Text] [Related]
9. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
Stumpe KO; Agabiti-Rosei E; Zielinski T; Schremmer D; Scholze J; Laeis P; Schwandt P; Ludwig M;
Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):97-106. PubMed ID: 19124398
[TBL] [Abstract][Full Text] [Related]
10. [Local pulse pressure and regression of arterial wall hypertrophy during antihypertensive treatment. CELIMENE study. The Celiprolol Intima-Media Enalapril Efficacy study].
Boutouyrie P; Bussy C; Tropeano AI; Hayoz D; Hengstler J; Dartois N; Laloux B; Brunner H; Laurent S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):911-5. PubMed ID: 10989729
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
Kastelein JJ; Sager PT; de Groot E; Veltri E
Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
[TBL] [Abstract][Full Text] [Related]
12. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet; 1999 Jun; 353(9169):2001-7. PubMed ID: 10376614
[TBL] [Abstract][Full Text] [Related]
13. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
Gullestad L; Manhenke C; Aarsland T; Skårdal R; Fagertun H; Wikstrand J; Kjekshus J
Eur J Heart Fail; 2001 Aug; 3(4):463-8. PubMed ID: 11511433
[TBL] [Abstract][Full Text] [Related]
14. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.
Markus RA; Mack WJ; Azen SP; Hodis HN
Am J Clin Nutr; 1997 Apr; 65(4):1000-4. PubMed ID: 9094885
[TBL] [Abstract][Full Text] [Related]
15. The role of carotid arterial intima-media thickness in predicting clinical coronary events.
Hodis HN; Mack WJ; LaBree L; Selzer RH; Liu CR; Liu CH; Azen SP
Ann Intern Med; 1998 Feb; 128(4):262-9. PubMed ID: 9471928
[TBL] [Abstract][Full Text] [Related]
16. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
17. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Furberg CD; Adams HP; Applegate WB; Byington RP; Espeland MA; Hartwell T; Hunninghake DB; Lefkowitz DS; Probstfield J; Riley WA
Circulation; 1994 Oct; 90(4):1679-87. PubMed ID: 7734010
[TBL] [Abstract][Full Text] [Related]
18. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
[TBL] [Abstract][Full Text] [Related]
19. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
[TBL] [Abstract][Full Text] [Related]
20. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
